Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...

CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...

Despite a U.S. factory mixup, more Johnson & Johnson doses are becoming available in the U.S., marking the only single-shot vaccine option. So how effective is it and how does it compare to the Pfizer ...

(NEXSTAR) – The Moderna COVID-19 remains effective even after 6 months, the company said in a Tuesday update on its ongoing clinical trials. The study looked at 33 healthy adult participants in the ...

Vaccine experts told STAT that the data Moderna released May 18 from its phase I vaccine trial isn’t enough to show whether or not the vaccine will be effective. Moderna released data from an early ...

Moderna said its updated shot produced an 8.7-fold increase in protective antibodies against BA.2.86 in a clinical trial. Pfizer separately said its jab generated protective antibodies against that ...

A new preprint study suggests that Moderna’s COVID-19 vaccine may be significantly more effective against symptomatic disease from the delta variant compared to Pfizer-BioNTech’s vaccine, while the ...

Stream Connecticut News for free, 24/7, wherever you are. Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for ...

Moderna said Monday it has requested emergency clearance from the Food and Drug Administration for its coronavirus vaccine after new data confirms the vaccine is more than 94% effective in preventing ...

Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release ...